Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.20344/amp.19904 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel prognostic factors and combination therapy outcomes in Morbihan disease: insights from an Asian population.
BMC Ophthalmol
November 2024
Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #222 Banpo-daero, Seocho-gu, Seoul, 06591, Korea.
Purpose: This study aimed to identify novel prognostic factors for Morbihan disease (MD) treatment outcomes and evaluate the efficacy of combination therapy in an Asian population, addressing the gaps in current understanding of this rare condition.
Methods: We conducted a retrospective analysis of MD patients diagnosed and treated at a tertiary hospital between 2017 and 2023. Patients received combinations of oral medications (tetracycline, isotretinoin, corticosteroids), topical treatments (tacrolimus, ivermectin), and intralesional steroid injections.
A case of Morbihan disease treated with ivermectin.
Int J Dermatol
October 2024
Department of Dermatology, University of Illinois at Chicago, Chicago, IL, USA.
Case report: A therapeutic attempt to treat Morbihan disease with Baricitinib.
Heliyon
August 2024
Department of Dermatology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Article Synopsis
- A woman in her thirties diagnosed with Morbihan disease experienced limited improvement despite years of treatment.
- The introduction of Baricitinib led to a better health outcome for her, marking a significant shift in her treatment approach.
- This case report is the first to explore Baricitinib for Morbihan disease, aiming to open up new potential therapies for the condition.
Successful treatment of a Morbihan's disease patient after a therapeutic challenge: A case report and comprehensive literature review.
J Gen Fam Med
July 2024
Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran.
Article Synopsis
- Morbihan's disease is a rare condition that leads to chronic swelling of the face, with unclear causes related to blood vessel and lymphatic system issues.
- Traditional treatments are usually not effective, and there’s no widely accepted successful therapy for the condition.
- A case study of a 17-year-old male showed improvement using a new combination treatment of cromolyn sodium nasal spray and oral montelukast, which had not been previously reported for this syndrome.
Gnatophyma associated with Morbihan disease: An unusual form of rosacea successfully treated with ablative carbon dioxide laser.
J Cosmet Dermatol
October 2024
Dermatology Department, Habib Thameur Hospital, Tunis, Tunisia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!